All filters
Slidesets
HCV diagnosis and direct-acting antiviral agents -based treatment for HIV/HCV co-infected patients in a primary care setting in Maputo, Mozambique- Natalia Tamayo Antabak
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Ledipasvir/Sofosbuvir for Treatment of Hepatitis C Virus Infection in Rwanda: Results from the SHARED Trial- Emmanuel Musabeyezu
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Viral hepatitis in paediatrics (B and C)- Manal El-Sayed, MD, PhD
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Other special populations (PWID)- John Rwegasha, MBChB, M.MED, FRCP, MSc
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Alcoholic liver disease- Kosh Agarwal, MD
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Drug-induced liver disease: khat and other weeds- Asgeir Johannessen
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Parasitic infections (Schistosomiasis infection, Liver flukes)- Edford Sinkala, BScHB, MBChB, MMed, PhD, FRCP
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Fatty Liver disease- Mark Thursz, MRCP
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Point-of-care testing for hepatitis B virus infection in a community-based occupational health cohort in the Western Cape Province, South Africa- Nafiisah Chotun
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Management of Hepatocellular Carcinoma in Africa- Wendy Spearman, MBChB, FCP, FRCP, MMed, PhD
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Large-scale discovery and validation of blood and urinary discriminant metabolites as potential biomarkers for the diagnosis hepatocellular carcinoma in West Africa -Mei Ran Abellona
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Management of end-stage Liver Disease in Resource Limited Settings- Mark Sonderup
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
The establishment of hepatitis B care and treatment clinics in the United Republic of Tanzania: A demonstration project following WHO guidelines- John Rwegasha
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
New diagnostics to improve diagnosis of liver disease- Francesco Marinucci
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
NOhep Visionaries in Africa: Medical professionals leading the way towards hepatitis elimination- Jessica Hicks
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
TAF – The latest update, which questions remain to be answered?- Pietro Lampertico, MD, PhD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Hepatitis B Cure: From Discovery to Regulatory Endpoints in HBV clinical research: A summary of the AASLD/EASL statement- Fabien Zoulim, MD, PhD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
How does HBV interact with the immune system- Mala Maini, MD, PhD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Is immunomodulation really needed to cure HBV?- Harry Janssen, MD, PhD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Innate Immunity : TLR, RIG-I, STING and potential others- Adam Gehring, PhD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Adaptive Immunity: Therapeutic vaccination, checkpoint inhibition and potential others- Andre Boonstra, PhD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Entry inhibition- Stephan Urban, PhD
Presented at:
International Workshop on HBV Cure 2017